Stock UTRS MINERVA SURGICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Minerva Surgical, Inc.

Minerva Surgical, Inc. Stock price

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 03:59:45 2023-12-01 pm EST 		Intraday chart for Minerva Surgical, Inc. 5-day change 1st Jan Change
2.060 USD +10.16% +19.08% -53.89%
Nov. 13 Minerva Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Nov. 13 Earnings Flash (UTRS) MINERVA SURGICAL Reports Q3 Revenue $12M MT

Financials (USD)

Sales 2023 * 51.81 M Sales 2024 * 59.61 M Capitalization 18.29 M
Net income 2023 * -32.00 M Net income 2024 * -28.00 M EV / Sales 2023 *
0,35x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 *
0,31x
P/E ratio 2023 *
-0,51x
P/E ratio 2024 *
-0,71x
Employees 174
Yield 2023 *
-
Yield 2024 *
-
Free-Float 30.76%
More Fundamentals * Assessed data

Chart Minerva Surgical, Inc.

Dynamic Chart

Latest news about Minerva Surgical, Inc.

Minerva Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (UTRS) MINERVA SURGICAL Reports Q3 Revenue $12M MT
Minerva Surgical, Inc. cancelled the transaction announced on September 28, 2023 CI
Minerva Surgical, Inc. announced that it expects to receive $20 million in funding from Accelmed Partners CI
Transcript : Minerva Surgical, Inc., Q2 2023 Earnings Call, Aug 02, 2023 CI
Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13.4M MT
Minerva Surgical, Inc. Provides Earnings Guidance for the Fiscal Year 2023 CI
Minerva Surgical, Inc. Announces Resignation of Ross A. Jaffe from the Board and from the Compensation Committee of the Board CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Index CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Index CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Growth Index CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Growth Index CI
Sector Update: Health Care Stocks Decline MT
Sector Update: Health Care Stocks Lower on Wednesday Afternoon MT
More news

Analyst Recommendations on Minerva Surgical, Inc.

Piper Sandler Adjusts Minerva Surgical's Price Target to $1 From $5, Keeps Overweight Rating MT
JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overweight Rating MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $6 From $12, Reiterates Overweight Rating MT
UBS Adjusts Minerva Surgical Price Target to $14 From $15, Maintains Buy Rating MT
More recommendations

Press releases Minerva Surgical, Inc.

Minerva Surgical Reports Third Quarter 2023 Financial Results AQ
Minerva Surgical : Modification to Rights of Security Holders - Form 8-K PU
Minerva Surgical : Announces 1-for-20 Reverse Stock Split - Form 8-K PU
Minerva Surgical : Announces 1-for-20 Reverse Stock Split PU
Minerva Surgical : to Present at the H.C. Wainwright 25th Annual Global Investment Conference PU
More press releases

Quotes and Performance

1 day+10.16%
1 week+19.08%
Current month+10.16%
1 month-31.56%
3 months-50.36%
6 months-64.85%
Current year-53.89%
More quotes

Highs and lows

1 week
1.56
Extreme 1.56
2.25
1 month
1.55
Extreme 1.55
2.83
Current year
1.55
Extreme 1.55
14.00
1 year
1.55
Extreme 1.55
14.00
3 years
1.55
Extreme 1.55
207.40
5 years
1.55
Extreme 1.55
207.40
10 years
1.55
Extreme 1.55
207.40
More quotes

Managers and Directors - Minerva Surgical, Inc.

Managers TitleAgeSince
Todd Usen CEO
 Chief Executive Officer - Jan. 01
Joel R. Jung DFI
 Director of Finance/CFO 65 2020
Eugene V. Skalnyi CTO
 Chief Tech/Sci/R&D Officer 57 2010
Members of the board TitleAgeSince
Uri Geiger CHM
 Chairman 55 Feb. 08
Ali Behbahani BRD
 Director/Board Member 46 2011
Derrick Sung BRD
 Director/Board Member 50 2022
More insiders

Quotes

Date Price Change Volume
23-12-01 2.060 +10.16% 48,548
23-11-30 1.870 +19.87% 136,898
23-11-29 1.560 -4.88% 16,379
23-11-28 1.640 -1.20% 15,820
23-11-27 1.660 -4.05% 8,171

Delayed Quote Nasdaq, December 01, 2023 at 03:59 pm EST

More quotes

Company Profile

Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-03-04 - Q4 2023 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Minerva Surgical, Inc.

Trading Rating :
Investor Rating :
ESG Refinitiv :
-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.060USD
Average target price
3.000USD
Spread / Average Target
+45.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
MINERVA SURGICAL, INC. Stock Minerva Surgical, Inc.
-53.89% 18 M $
STRYKER CORPORATION Stock Stryker Corporation
+21.80% 113 B $
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-6.67% 11 448 M $
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-47.38% 9 012 M $
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-39.76% 4 479 M $
GLAUKOS CORPORATION Stock Glaukos Corporation
+49.11% 3 176 M $
AXONICS, INC. Stock Axonics, Inc.
-8.04% 2 913 M $
ENOVIS CORPORATION Stock Enovis Corporation
-4.76% 2 783 M $
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
+7.49% 2 653 M $
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
+19.37% 2 356 M $
Medical Devices & Implants
  1. Stock
  2. Equities
  3. Stock Minerva Surgical, Inc. - Nasdaq
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer